Tocilizumab improves systemic and laboratory features of Systemic Juvenile Idiopathic Arthritis: 12-week data from the Phase 3 TENDER Trial

F. De Benedetti; Bambin Gesu Rome; N. Ruperto; H. Brunner; E. Baildam; R. Burgos; P. Dolezalova; S. Garay; J. Garcia-Consuegra; R. Joos; N. Wulffraat; Z. Zuber; F. Zulian; A. Grom; F. Schaefer; S. Wright; A. Kenwright; A. Martini; D. Lovell

Tocilizumab improves systemic and laboratory features of Systemic Juvenile Idiopathic Arthritis: 12-week data from the Phase 3 TENDER Trial

F. De Benedetti
, Bambin Gesu Rome
, N. Ruperto
, H. Brunner
, E. Baildam
, R. Burgos
, P. Dolezalova
, S. Garay
, J. Garcia-Consuegra
, R. Joos
, N. Wulffraat
, Z. Zuber
, F. Zulian
, A. Grom
, F. Schaefer
, S. Wright
, A. Kenwright
, A. Martini
, D. Lovell

Infection & Immunity

Research output: Contribution to journal › Meeting Abstract › Academic

Original language	English
Pages (from-to)	415-415
Journal	Clinical and Experimental Rheumatology
Volume	29
Issue number	2
Publication status	Published - 2011

Cite this

De Benedetti, F., Rome, B. G., Ruperto, N., Brunner, H., Baildam, E., Burgos, R., Dolezalova, P., Garay, S., Garcia-Consuegra, J., Joos, R., Wulffraat, N., Zuber, Z., Zulian, F., Grom, A., Schaefer, F., Wright, S., Kenwright, A., Martini, A., & Lovell, D. (2011). Tocilizumab improves systemic and laboratory features of Systemic Juvenile Idiopathic Arthritis: 12-week data from the Phase 3 TENDER Trial. Clinical and Experimental Rheumatology, 29(2), 415-415.

@article{7ab7a580cc6f4546bbea32c2257800ed,

title = "Tocilizumab improves systemic and laboratory features of Systemic Juvenile Idiopathic Arthritis: 12-week data from the Phase 3 TENDER Trial",

author = "\{De Benedetti\}, F. and Rome, \{Bambin Gesu\} and N. Ruperto and H. Brunner and E. Baildam and R. Burgos and P. Dolezalova and S. Garay and J. Garcia-Consuegra and R. Joos and N. Wulffraat and Z. Zuber and F. Zulian and A. Grom and F. Schaefer and S. Wright and A. Kenwright and A. Martini and D. Lovell",

year = "2011",

language = "English",

volume = "29",

pages = "415--415",

journal = "Clinical and Experimental Rheumatology",

issn = "0392-856X",

publisher = "Clinical and Experimental Rheumatology S.A.S.",

number = "2",

}

De Benedetti, F, Rome, BG, Ruperto, N, Brunner, H, Baildam, E, Burgos, R, Dolezalova, P, Garay, S, Garcia-Consuegra, J, Joos, R, Wulffraat, N, Zuber, Z, Zulian, F, Grom, A, Schaefer, F, Wright, S, Kenwright, A, Martini, A & Lovell, D 2011, 'Tocilizumab improves systemic and laboratory features of Systemic Juvenile Idiopathic Arthritis: 12-week data from the Phase 3 TENDER Trial', Clinical and Experimental Rheumatology, vol. 29, no. 2, pp. 415-415.

TY - JOUR

T1 - Tocilizumab improves systemic and laboratory features of Systemic Juvenile Idiopathic Arthritis: 12-week data from the Phase 3 TENDER Trial

AU - De Benedetti, F.

AU - Rome, Bambin Gesu

AU - Ruperto, N.

AU - Brunner, H.

AU - Baildam, E.

AU - Burgos, R.

AU - Dolezalova, P.

AU - Garay, S.

AU - Garcia-Consuegra, J.

AU - Joos, R.

AU - Wulffraat, N.

AU - Zuber, Z.

AU - Zulian, F.

AU - Grom, A.

AU - Schaefer, F.

AU - Wright, S.

AU - Kenwright, A.

AU - Martini, A.

AU - Lovell, D.

PY - 2011

Y1 - 2011

M3 - Meeting Abstract

SN - 0392-856X

VL - 29

SP - 415

EP - 415

JO - Clinical and Experimental Rheumatology

JF - Clinical and Experimental Rheumatology

IS - 2

ER -